Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team.
Our next presenting company is Amicus and presenting on behalf of the company, we have, CEO, John Crowley. Before I turn it over to John, (Operator Instructions)
With that, I'll pass it over to you, John.
Great. Good morning, Anupam. Good morning, everybody. Thank you, JPMorgan, for hosting. I will mention that I'll be making forward-looking statements, and we'll refer you to our forward-looking statements section on Slide 2.
Let me begin though on Slide 3, and this is really the foundation of Amicus. Again, what we've been striving to achieve over the last several years and now looking out to the future is to build a great biotechnology company. And this slide on 3 here really shows you the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |